You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In

Vol. 203 No. 13, March 25, 1968 TABLE OF CONTENTS
  JAMA
 •  Online Features
ARTICLES
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

An Agent for the Amelioration of Vertigo in Ménière's Syndrome

Betahistine Hydrochloride (Serc)

JAMA. 1968;203(13):1122.


Abstract

Betahistine hydrochloride is effective in alleviating the recurrent attacks of vertigo that are associated with Ménière's syndrome. In general, adverse effects observed from its use have been minor and infrequent.



Footnotes

Scientific data on betahistine hydrochloride were supplied to the Council by Unimed, Inc., Morristown, NJ.

Reprint requests to Secretary, Council on Drugs, American Medical Association, 535 N Dearborn St, Chicago 60610.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.